Medifocus Guidebook on: Non-Hodgkin's Lymphoma
The MediFocus Guidebook on Non-Hodgkin's Lymphoma is the most comprehensive, up-to-date source of information available. You will get answers to your questions, including risk factors of Non-Hodgkin's Lymphoma, standard and alternative treatment options, leading doctors, hospitals and medical centers that specialize in Non-Hodgkin's Lymphoma, results of the latest clinical trials, support groups and additional resources, and promising new treatments on the horizon. This one of a kind Guidebook offers answers to your critical health questions including the latest treatments, clinical trials, and expert research; high quality, professional level information you can trust and understand culled from the latest peer-reviewed journals; and a unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks. This Guidebook was updated on February 2, 2012.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Abstract Link ABSTRACT NOT AVAILABLE acupuncture aggressive non-Hodgkin's lymphoma allogeneic stem cell Anderson Cancer Center Bendamustine biopsy blood cells Bone Marrow Transplantation CAM therapies cancer cells cancer pain cancer specialist cancer treatments cancer-related pain Clin Oncol College of Medicine Comprehensive Cancer Center conventional treatments cyclophosphamide Department of Hematology Department of Internal Department of Medicine Department of Pediatrics disease Division of Hematology Division of Hematology/Oncology drugs Epub etoposide Gazi University Germany GVHD Haematol Hematology Hematology and Oncology high-dose chemotherapy Houston immune infection Institutional Affiliation Department Internal Medicine Italy Journal Leuk Lymphoma Leukemia lymph node lymphatic system lymphoma cells malignancies Massachusetts General Hospital Medical Oncology Medical School monoclonal antibody Name of Author non-Hodgkin's lymphoma non-Hodgkin's lymphoma NHL pain medications patients with non-Hodgkin's prognosis radiation therapy Radioimmunotherapy regimen Rituxan rituximab Rochester side-effects stem cell transplantation tissue treatment of non-Hodgkin's treatment options tumor University Hospital University of Texas University of Ulsan York